NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND)

Historical Holders from Q1 2022 to Q3 2025

Type / Class
Equity / NYLI US LC R&D L
Symbol
LRND
Price per share
$39.79
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
203,087
Total reported value
$8,081,257
% of total 13F portfolios
0%
Share change
-3,462
Value change
-$137,036
Avg sell value change
-0%
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) has 2 institutional shareholders filing 13F forms. They hold 203,087 shares .

Institutional Holders of NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 203,087 $8,081,257 -$137,036 3,979.21% 2
2025 Q2 206,549 $7,454,512 -$77,164 3,609.19% 5
2025 Q1 208,832 $6,713,721 +$58,962 3,214.89% 4
2024 Q4 206,998 $7,066,781 +$275,251 3,413.94% 3
2024 Q3 198,937 $6,623,607 +$30,398 3,329.5% 3
2024 Q2 198,024 $6,486,569 -$92,017 3,275.62% 2
2024 Q1 201,283 $6,330,351 -$242,534 3,145% 3
2023 Q4 211,080 $5,981,719 +$597,357 2,829.43% 4
2023 Q3 190,001 $4,774,459 -$771 2,506.43% 2
2023 Q2 190,031 $4,887,350 +$797 2,571.87% 3
2023 Q1 190,000 $4,361,336 2,295.44% 1
2022 Q4 190,000 $3,787,498 1,993.42% 1
2022 Q3 190,000 $3,648,000 1,920% 1
2022 Q2 190,000 $190,000 -$4,782,000 100% 1
2022 Q1 380,000 $9,564,000 +$9,564,000 2,516.84% 2